Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 14 results
Author
Title
Type
Year
Filters:
Author
is
Rickman, David S
[Clear All Filters]
Journal Article
Gayvert KM
,
Dardenne E
,
Cheung C
,
Boland MRegina
,
Lorberbaum T
,
Wanjala J
,
Chen Y
,
Rubin MA
,
Tatonetti NP
,
Rickman DS
et al.
. 2016.
A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors.
.
Cell Rep. 15(11):2348-56.
Pflueger D
,
Terry S
,
Sboner A
,
Habegger L
,
Esgueva R
,
Lin P-C
,
Svensson MA
,
Kitabayashi N
,
Moss BJ
,
MacDonald TY
et al.
. 2011.
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.
.
Genome Res. 21(1):56-67.
Demichelis F
,
Setlur SR
,
Beroukhim R
,
Perner S
,
Korbel JO
,
Lafargue CJ
,
Pflueger D
,
Pina C
,
Hofer MD
,
Sboner A
et al.
. 2009.
Distinct genomic aberrations associated with ERG rearranged prostate cancer.
.
Genes Chromosomes Cancer. 48(4):366-80.
Perner S
,
Wagner PL
,
Demichelis F
,
Mehra R
,
Lafargue CJ
,
Moss BJ
,
Arbogast S
,
Soltermann A
,
Weder W
,
Giordano TJ
et al.
. 2008.
EML4-ALK fusion lung cancer: a rare acquired event.
.
Neoplasia. 10(3):298-302.
Rickman DS
,
Chen Y-B
,
Banerjee S
,
Pan Y
,
Yu J
,
Vuong T
,
Perner S
,
Lafargue CJ
,
Mertz KD
,
Setlur SR
et al.
. 2010.
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.
.
Neoplasia. 12(12):1031-40.
Perner S
,
Svensson MA
,
Hossain RR
,
Day JR
,
Groskopf J
,
Slaughter RC
,
Jarleborn AR
,
Hofer MD
,
Kuefer R
,
Demichelis F
et al.
. 2010.
ERG rearrangement metastasis patterns in locally advanced prostate cancer.
.
Urology. 75(4):762-7.
Demichelis F
,
Setlur SR
,
Banerjee S
,
Chakravarty D
,
Chen JYun Helen
,
Chen CX
,
Huang J
,
Beltran H
,
Oldridge DA
,
Kitabayashi N
et al.
. 2012.
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
.
Proc Natl Acad Sci U S A. 109(17):6686-91.
Beltran H
,
Rickman DS
,
Park K
,
Chae SSuk
,
Sboner A
,
MacDonald TY
,
Wang Y
,
Sheikh KL
,
Terry S
,
Tagawa ST
et al.
. 2011.
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
.
Cancer Discov. 1(6):487-95.
Esgueva R
,
Park K
,
Kim R
,
Kitabayashi N
,
Barbieri CE
,
Dorsey PJ
,
Abraham C
,
Banerjee S
,
Leung RA
,
Tewari AK
et al.
. 2012.
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.
.
Diagn Mol Pathol. 21(2):61-8.
Pflueger D
,
Rickman DS
,
Sboner A
,
Perner S
,
Lafargue CJ
,
Svensson MA
,
Moss BJ
,
Kitabayashi N
,
Pan Y
,
de la Taille A
et al.
. 2009.
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.
.
Neoplasia. 11(8):804-11.
Dardenne E
,
Beltran H
,
Benelli M
,
Gayvert K
,
Berger A
,
Puca L
,
Cyrta J
,
Sboner A
,
Noorzad Z
,
MacDonald T
et al.
. 2016.
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.
.
Cancer Cell. 30(4):563-577.
Rickman DS
,
T Soong D
,
Moss B
,
Mosquera JMiguel
,
Dlabal J
,
Terry S
,
MacDonald TY
,
Tripodi J
,
Bunting K
,
Najfeld V
et al.
. 2012.
Oncogene-mediated alterations in chromatin conformation.
.
Proc Natl Acad Sci U S A. 109(23):9083-8.
Rickman DS
,
Pflueger D
,
Moss B
,
VanDoren VE
,
Chen CX
,
de la Taille A
,
Kuefer R
,
Tewari AK
,
Setlur SR
,
Demichelis F
et al.
. 2009.
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
.
Cancer Res. 69(7):2734-8.
Beltran H
,
Eng K
,
Mosquera JMiguel
,
Sigaras A
,
Romanel A
,
Rennert H
,
Kossai M
,
Pauli C
,
Faltas B
,
Fontugne J
et al.
. 2015.
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
.
JAMA Oncol. 1(4):466-74.